Cargando…
Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
BACKGROUND: In 2014, Gavi and partners developed a global Immunization Supply Chain (iSC) Strategy, 2015–2020, which prioritized functioning cold chain equipment (CCE) and additional storage capacity. In 2016, Gavi launched the Cold Chain Equipment Optimization Platform (CCEOP) as a funding mechanis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540167/ https://www.ncbi.nlm.nih.gov/pubmed/36207724 http://dx.doi.org/10.1186/s12913-022-08616-9 |
_version_ | 1784803651567484928 |
---|---|
author | Prosser, Wendy Sagar, Karan Seidel, Michelle Alva, Soumya |
author_facet | Prosser, Wendy Sagar, Karan Seidel, Michelle Alva, Soumya |
author_sort | Prosser, Wendy |
collection | PubMed |
description | BACKGROUND: In 2014, Gavi and partners developed a global Immunization Supply Chain (iSC) Strategy, 2015–2020, which prioritized functioning cold chain equipment (CCE) and additional storage capacity. In 2016, Gavi launched the Cold Chain Equipment Optimization Platform (CCEOP) as a funding mechanism to improve CCE availability. In 2018, Gavi commissioned an evaluation of CCEOP in Guinea, Kenya and Pakistan. The global iSC Strategy has recently been revised, drawing on findings from effective vaccine management assessments and practical experiences. This case study presents the CCEOP evaluation and how its findings reinforced the revision of the iSC strategy. METHODS: The CCEOP evaluation used a prospective mixed-methods research design in all three countries involving key informant interviews at multiple levels of the health system, document reviews, direct observation (as and when possible), and a health facility assessment. RESULTS: Results show that CCEOP was effective at increasing the number of available and reliable CCE, and establishing improved management processes using the project management team (PMT) approach for country management systems and the service bundle provider approach for installation and maintenance. CCEOP also extended the iSC and immunization services in countries. The evaluation results also show gaps in the overall supply chain system, including CCE maintenance. DISCUSSION: Gavi has recently revised its iSC strategy, which has addressed gaps identified through assessments and practical experiences from stakeholders. Results of the CCEOP evaluation reinforce many of these findings. The strategy now provides more emphasis on supporting the fundamental infrastructure and establishing strong processes for maintenance. It also emphasizes strategic planning and forward thinking for iSC decisions, building on the processes established for the PMT through CCEOP. The original iSC strategy was an impetus for the establishment of CCEOP. The new strategy reflects shifting trends and priorities to fill gaps identified through practical experience, advocated for by stakeholders and thought leaders engaged in the iSC, and validated by the evaluation. It demonstrates the importance of aligning stakeholders with clear objectives and a sound strategy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-08616-9. |
format | Online Article Text |
id | pubmed-9540167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95401672022-10-08 Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy Prosser, Wendy Sagar, Karan Seidel, Michelle Alva, Soumya BMC Health Serv Res Research BACKGROUND: In 2014, Gavi and partners developed a global Immunization Supply Chain (iSC) Strategy, 2015–2020, which prioritized functioning cold chain equipment (CCE) and additional storage capacity. In 2016, Gavi launched the Cold Chain Equipment Optimization Platform (CCEOP) as a funding mechanism to improve CCE availability. In 2018, Gavi commissioned an evaluation of CCEOP in Guinea, Kenya and Pakistan. The global iSC Strategy has recently been revised, drawing on findings from effective vaccine management assessments and practical experiences. This case study presents the CCEOP evaluation and how its findings reinforced the revision of the iSC strategy. METHODS: The CCEOP evaluation used a prospective mixed-methods research design in all three countries involving key informant interviews at multiple levels of the health system, document reviews, direct observation (as and when possible), and a health facility assessment. RESULTS: Results show that CCEOP was effective at increasing the number of available and reliable CCE, and establishing improved management processes using the project management team (PMT) approach for country management systems and the service bundle provider approach for installation and maintenance. CCEOP also extended the iSC and immunization services in countries. The evaluation results also show gaps in the overall supply chain system, including CCE maintenance. DISCUSSION: Gavi has recently revised its iSC strategy, which has addressed gaps identified through assessments and practical experiences from stakeholders. Results of the CCEOP evaluation reinforce many of these findings. The strategy now provides more emphasis on supporting the fundamental infrastructure and establishing strong processes for maintenance. It also emphasizes strategic planning and forward thinking for iSC decisions, building on the processes established for the PMT through CCEOP. The original iSC strategy was an impetus for the establishment of CCEOP. The new strategy reflects shifting trends and priorities to fill gaps identified through practical experience, advocated for by stakeholders and thought leaders engaged in the iSC, and validated by the evaluation. It demonstrates the importance of aligning stakeholders with clear objectives and a sound strategy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-022-08616-9. BioMed Central 2022-10-07 /pmc/articles/PMC9540167/ /pubmed/36207724 http://dx.doi.org/10.1186/s12913-022-08616-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Prosser, Wendy Sagar, Karan Seidel, Michelle Alva, Soumya Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title | Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title_full | Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title_fullStr | Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title_full_unstemmed | Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title_short | Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy |
title_sort | ensuring vaccine potency and availability: how evidence shaped gavi's immunization supply chain strategy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540167/ https://www.ncbi.nlm.nih.gov/pubmed/36207724 http://dx.doi.org/10.1186/s12913-022-08616-9 |
work_keys_str_mv | AT prosserwendy ensuringvaccinepotencyandavailabilityhowevidenceshapedgavisimmunizationsupplychainstrategy AT sagarkaran ensuringvaccinepotencyandavailabilityhowevidenceshapedgavisimmunizationsupplychainstrategy AT seidelmichelle ensuringvaccinepotencyandavailabilityhowevidenceshapedgavisimmunizationsupplychainstrategy AT alvasoumya ensuringvaccinepotencyandavailabilityhowevidenceshapedgavisimmunizationsupplychainstrategy |